While several molecular markers that are used to evaluate the development and prognosis of bladder cancer have been studied, the limited value of these established markers has created the need for ...

Recent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk ...

Recent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk localized, muscle-invasive disease, according to a new editorial.

Currently, patients with bladder cancer are monitored for cancer recurrence or progression by periodic cystoscopy and urine cytology, the frequency of which varies depending on the risk factors ...

The promise of incorporating new treatments and predictive biomarkers to select the right patient for the right treatment every time offers a bright future for bladder cancer patients.

Cxbladder Detect quantifies the presence of RNA biomarkers, the increased expression of which is correlated with the presence of bladder cancer. In particular, this test is designed for high-risk ...

Matthew Milowsky, MD, FASCO, a bladder cancer expert at UNC School of Medicine and UNC Lineberger Comprehensive Cancer Center, wrote that the promise of incorporating new treatments and predictive ...

The accelerated approval of Trodelvy for patients with metastatic urothelial cancer has been voluntarily withdrawn.

MIBC is an advanced form of bladder cancer ... whether it showed elevated levels of PD-L1, a protein biomarker that plays a role in cancer. Professor Thomas Powles of Barts Cancer Institute ...

Over the last decade, bladder cancer incidence rates have decreased by almost a sixth (16%) in the UK. Rates in females have decreased by around a seventh (15%), and rates in males have decreased by ...